4.7 Article

SUMO modification regulates the transcriptional activity of MAML1

期刊

FASEB JOURNAL
卷 24, 期 7, 页码 2396-2404

出版社

FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.09-149401

关键词

HDAC; coactivator; Notch

资金

  1. Swedish Research Council
  2. Swedish Cancer Society
  3. Swedish Children's Cancer Foundation

向作者/读者索取更多资源

The Mastermindlike ( MAML) family, comprising human MAML1, MAML2, and MAML3, are transcriptional regulators in Notch signaling. MAML proteins contain two consensus sites for SUMOylation at Lysine217 and Lysine299 that are conserved in humans, mice, and Xenopus. In this report, we show that MAML1 is SUMOylated at both sites. The E2-conjugating enzyme UBC9 is essential for MAML1 SUMOylation, and the E3 ligase PIAS1 stimulates this activity. Mutation of the lysines abolishes SUMOylation of MAML1 and strongly increases MAML1-activated transcription in cell culture assays. The protease SENP1 reverses SUMOylation of MAML1 and potentiates the transcription factor activity of MAML1. Furthermore, SUMOylation enhances MAML1 interaction with HDAC7, which decreases MAML1 transcriptional activity. Taken together, our data indicate that SUMOylation of MAML1 is a mechanism for repressing MAML1 activity by influencing its interaction with HDAC7.-Lindberg, M.J., Popko-Scibor, A.E., Hansson, M.L., Wallberg, A. E. SUMO modification regulates the transcriptional activity of MAML1. FASEB J. 24, 2396-2404 (2010). www.fasebj.org

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据